[...] he and two classmates formed Eko Devices, raising nearly $5 million and selling 6,000 digital stethoscopes, used in 700 hospitals.The Berkeley company’s wireless stethoscopes can transfer a patient’s heart rate and other vital signs directly to Eko’s secure portal, where it can, among other things, be shared with doctors for a second opinion.The product, which fits in your hand, combines electrocardiogram readings and heart sounds into a device that allows patients to monitor their health at home and send data to their physicians.The Duo gives at-home heart patients “a cardiology-level exam” said Dr. Ami Bhatt, director of outpatient cardiology at Massachusetts General and an assistant professor of medicine at Harvard University.Bhatt, a scientific adviser to Eko who will be compensated with a small stock option for her work, said that tracking patients, wherever they live, will allow cardiologists to intervene “before a crisis.”Other doctors say that it is too soon to tell how helpful telemedicine devices — which include home monitoring devices for diabetes, asthma and sleep disorders — will be, given the many obstacles.“Medicine is experiencing a potentially tectonic shift,” said Dr. Jeffrey Olgin, professor and chief of cardiology at UCSF’s School of Medicine, who conducts research into mobile and digital health.Telemedicine is a $9.2 billion business, said Bruce Carlson, publisher of Kalorama Information, a health care market-research firm in New York.If Eko’s devices reach even 10 percent of its target market, Bellet said, “It turns it into a $1.2 billion company.”From Eko’s airy Berkeley offices, Landgraf demonstrated the Duo. “l’ll just slip it under my shirt,” he said, scooping up the one-button device, which resembles a cell phone for preschoolers.“There is a black space,” said Dr. Robert Pearl, a lecturer on health care policy at Stanford’s medical and business schools and, until recently, the CEO of Kaiser Permanente Medical Group, which represents 10,000 physicians.The Centers for Disease Control and Prevention estimates that 610,000 people die of heart failure in the United States every year, making it the leading cause of death.[...] senior design project in bioengineering, she built a device for asthma patients.Five years later, she is chief executive of Knox Medical Diagnostics, a San Francisco startup that has developed a device for children with asthma to monitor their health at home, sending results to a smartphone app.Shetty’s device is a portable spirometer that measures airway obstructions and the severity of inflammation in a child’s lungs and, she said, alerts a parent before a child has an asthma attack.After testing her device with asthmatic children, Shetty added a video game to the app, to encourage young patients to use the device effectively while keeping them engaged.
NYS Entity Status
NYS Filing Date
MAY 02, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2014 - MEDICAL CARDIOLOGY CARE, PLLC
Around the Web
- Heart and asthma monitors? There’s an app for that
By Carol Pogash - Friday Aug 11, 2017
- Neighborhood Demographics and Cardiac Arrest Treatments and Outcomes
Tuesday Oct 3, 2017
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.
- Care Convene Aims to Make Telemedicine as User-Friendly as Facebook
By Sarah Schmid Stevenson - Thursday Aug 10, 2017
Jefferey VanWingen is a family doctor who has been practicing medicine for 17 years. Although he’s based in Grand Rapids, MI, he’s also been taking medical missions to India for the past decade. It’s always been his goal to use technology to bridge his physical distance from the Wi-Fi-enabled community he works with in India. […]
- Traces of Crime: How New York’s DNA Techniques Became Tainted
By LAUREN KIRCHNER - Monday Sep 4, 2017
The city’s medical examiner has been a pioneer in analyzing complex DNA samples. But two methods were recently discontinued, raising questions about thousands of cases.
- Man Killed in 9/11 Attacks Is Identified by DNA Testing
By ASHLEY SOUTHALL - Monday Aug 7, 2017
The man, whose name was withheld by officials at his family’s request, was the first Sept. 11 victim to be identified in more than two years.
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]